| Three Months Ending | ||||||||
| June 30, 2022 | ||||||||
| Low | High | |||||||
| R&D and SG&A expense | $ | 132,700 | $ | 136,700 | ||||
| Adjustments to reconcile R&D and SG&A expense to non-GAAP R&D and SG&A expense: | ||||||||
| Stock-based compensation expense | (42,700 | ) | (44,700 | ) | ||||
| Non-GAAP R&D and SG&A expense | $ | 90,000 | $ | 92,000 | ||||
